Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Imcyse completes enrolment in Phase Ib trial of Imotopes

Type 1 diabetes is estimated to affect more than 40 million people worldwide. Credit: Bradley Johnson.



  • Imcyse

Go Top